Tasso announces CE Mark for Tasso+™ lancet, achieving EU market access and joining prior U.S. 510(k) clearance

Tasso announced CE Mark certification for its Tasso+™ virtually pain-free whole blood collection lancet, enabling sales across the EU and marking full clearance after prior FDA 510(k) Class II clearance; the device aims to expand decentralized clinical trials, home diagnostics, and remote testing access in Europe.